PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TransMedics Group, Inc. (TMDX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US89377M1099

CUSIP

89377M109

Sector

Healthcare

IPO Date

May 2, 2019

Highlights

Market Cap

$2.21B

EPS (TTM)

$0.93

PE Ratio

70.65

Total Revenue (TTM)

$401.09M

Gross Profit (TTM)

$237.79M

EBITDA (TTM)

$58.14M

Year Range

$60.80 - $177.37

Target Price

$102.00

Short %

33.67%

Short Ratio

4.14

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
TMDX vs. VOO TMDX vs. NVDA TMDX vs. SPY TMDX vs. FTNT TMDX vs. DXCM TMDX vs. BTC-USD TMDX vs. LLY TMDX vs. NVO TMDX vs. TJX TMDX vs. GCT
Popular comparisons:
TMDX vs. VOO TMDX vs. NVDA TMDX vs. SPY TMDX vs. FTNT TMDX vs. DXCM TMDX vs. BTC-USD TMDX vs. LLY TMDX vs. NVO TMDX vs. TJX TMDX vs. GCT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in TransMedics Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-55.99%
8.81%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Returns By Period

TransMedics Group, Inc. had a return of -22.48% year-to-date (YTD) and -20.78% in the last 12 months.


TMDX

YTD

-22.48%

1M

-26.21%

6M

-57.51%

1Y

-20.78%

5Y*

26.91%

10Y*

N/A

^GSPC (Benchmark)

YTD

24.66%

1M

0.49%

6M

8.64%

1Y

26.56%

5Y*

13.06%

10Y*

11.10%

Monthly Returns

The table below presents the monthly returns of TMDX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20248.67%-4.86%-9.39%27.31%44.91%10.43%-5.55%18.14%-6.58%-47.79%5.78%-22.48%
20232.11%27.05%-5.42%4.45%-8.14%15.58%10.95%-29.57%-16.58%-31.54%101.92%4.29%27.88%
2022-17.17%16.70%45.46%-22.20%39.17%7.82%28.39%28.85%-19.78%15.52%28.31%-0.24%222.13%
202114.47%57.55%15.60%-30.80%-10.69%29.41%-14.04%14.59%1.25%-17.10%-19.65%-13.07%-3.72%
2020-7.89%-10.34%-23.06%49.75%-26.98%35.65%0.78%-1.27%-22.71%-13.06%24.12%33.83%4.68%
201921.60%6.62%-18.14%0.93%-0.84%-24.46%4.52%1.39%-14.98%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TMDX is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TMDX is 3333
Overall Rank
The Sharpe Ratio Rank of TMDX is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of TMDX is 3535
Sortino Ratio Rank
The Omega Ratio Rank of TMDX is 3535
Omega Ratio Rank
The Calmar Ratio Rank of TMDX is 3030
Calmar Ratio Rank
The Martin Ratio Rank of TMDX is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for TMDX, currently valued at -0.30, compared to the broader market-4.00-2.000.002.00-0.302.12
The chart of Sortino ratio for TMDX, currently valued at 0.01, compared to the broader market-4.00-2.000.002.004.000.012.83
The chart of Omega ratio for TMDX, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.39
The chart of Calmar ratio for TMDX, currently valued at -0.32, compared to the broader market0.002.004.006.00-0.323.13
The chart of Martin ratio for TMDX, currently valued at -0.87, compared to the broader market0.0010.0020.00-0.8713.67
TMDX
^GSPC

The current TransMedics Group, Inc. Sharpe ratio is -0.30. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of TransMedics Group, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.30
2.12
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


TransMedics Group, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-65.26%
-2.37%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the TransMedics Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TransMedics Group, Inc. was 73.69%, occurring on Feb 23, 2022. Recovery took 113 trading sessions.

The current TransMedics Group, Inc. drawdown is 65.26%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-73.69%Mar 23, 2021234Feb 23, 2022113Aug 5, 2022347
-65.63%Aug 28, 202480Dec 19, 2024
-65.47%May 23, 2019205Mar 16, 2020228Feb 9, 2021433
-61.76%Jul 19, 202373Oct 30, 2023124Apr 29, 2024197
-29.9%Sep 13, 202224Oct 14, 202215Nov 4, 202239

Volatility

Volatility Chart

The current TransMedics Group, Inc. volatility is 24.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
24.28%
3.87%
TMDX (TransMedics Group, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of TransMedics Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for TransMedics Group, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab